CardiologyNOW | View Sessions On Demand | Pri-Med

Thank you to all who joined us live for CardiologyNOW: A Pri-Med Virtual Conference on Thursday, September 30, 2021. If you were not able to join us, most sessions have been recorded and are available below.

Upcoming Virtual Conferences
Pri-Med has more virtual education planned. View our upcoming programs.

Upcoming Conferences


Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Cardiology

 

With the COVID-19 pandemic moving through the country, it is important for clinicians to have the most up-to-date information. Join this session with Dr. Peter Libby to learn about the cardiovascular complications of COVID-19 and how you can help patients facing these issues. 

Peter Libby, MD

Cardiovascular Specialist, Brigham and Women's Hospital, Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, MA

9:10–10:10am ET    CME/CE Accredited Session

Cardiology

Beating the Odds: New Advances in Overcoming the Challenges of HFrEF  

Ty J. Gluckman, MD, FACC, FAHA | Alison L. Bailey, MD, FACC, FAACVPR

 

In recent years, promising evidence has emerged for new pharmacologic treatments for heart failure with reduced ejection fraction (HFrEF); however, gaps in clinician prescribing for the current guideline-directed therapies still exist. Join cardiology experts Ty Gluckman, MD, and Alison Bailey, MD, as they review the current recommendations for guideline-directed medical therapy in HFrEF, discuss strategies for implementing it, and assess the evidence for new and emerging treatments for HFrEF and recently approved agents, including SGLT2 inhibitors, vericiguat, and omecamtiv mecarbil.

Ty J. Gluckman, MD, FACC, FAHA

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health, Portland, OR

Default Biography Avatar

Alison L. Bailey, MD, FACC, FAACVPR

Governor, Tennessee Chapter of the American College of Cardiology, Chattanooga, TN

Supported by Merck Sharp & Dohme Corp.

10:20–11:05am ET    Non-CME Industry Theater

Cardiology

The Continuum of Heart Failure

Kris Vijay, MD, MS, FACP, FACC, FNLA, FCRS, FHFSA

 

The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.

Kris Vijay, MD, MS, FACP, FACC, FNLA, FCRS, FHFSA

Medical Director, CHF, Abrazo Arizona, Heart Hospital and Abrazo Health, Network, Clinical Professor of Medicine, University, of Arizona, Founding Member and Past President,, Cardiorenal Society of America (CRSA)

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

11:15am–12:15pm ET    CME/CE Accredited Session

Cardiology

Taking Diabetes to Heart: Using Antihyperglycemic Agents to Reduce Cardiovascular Risk

Christopher Cannon, MD | Tina Kaur Thethi, MD, MPH

 

In recent years there has a been paradigm shift in how to individualize use of antihyperglycemic agents in people with type 2 diabetes, with cardiac history and risk factors significantly affecting the guideline-recommended agents. In addition metformin, SGLT2 inhibitors and GLP-1 receptor agonists have become an integral part of treatment of patients with diabetes and comorbid cardiac and renal disease. Join expert faculty in this data driven session as they review the and discuss strategies to improve use of these agents in management of type 2 diabetes.

Christopher Cannon, MD

Cardiovascular Division, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA

Tina Kaur Thethi, MD, MPH

Associate Investigator and Endocrinologist, AdventHealth, Translational Research Institute, Orlando, FL

Supported by Novo Nordisk Inc.

12:25–12:35pm ET    Non-CME Industry Theater

Cardiology

Hospitalization: An Opportunity to Optimize Care for Patients with Heart Failure

Jennifer Brown

 

A brief review on how hospitalizations impact heart failure trajectory and how guideline-directed care can improve outcomes for patients with heart failure. Dr. Jennifer Brown presents compelling information on why hemodynamic status and biomarkers (such as BNP and NT-proBNP) are important prognostic indicators in patients hospitalized due to heart failure. 

For more HF and cardiovascular disease education content, please see www.HallsofScience.com  

Default Biography Avatar

Jennifer Brown

Sponsored by Novartis Pharmaceuticals Corporation

12:40–12:50pm ET    Non-CME Industry Theater

Cardiology

Heart Failure with Preserved Ejection Fraction (HFpEF): An Overview

John Ryan

 

An overview of the patient demographics and comorbidities that drive the pathophysiology of disease and precipitate hospitalization for patients with HFpEF. Clinical guidelines are discussed, focusing on addressing risk factors and comorbid conditions, as well as phenotyping, which may assist in the management of patients with HFpEF.

For more HF and cardiovascular disease education content, please see www.HallsofScience.com

John Ryan

Sponsored by Novartis Pharmaceuticals Corporation